Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

L'importance de choisir judicieusement en oncologie chirurgicale

Share :

Choosing Wisely Senegal 2022
Published: 7 Feb 2023
Views: 166
Rating:
Save
Prof Sidy Ka - Cheikh Anta Diop University, Dakar, Senegal

Le professeur Sidy Ka parle à ecancer de Choisir judicieusement en oncologie chirurgicale.

Il résume son exposé qu'il a présenté lors de la réunion Choisir avec soin au Sénégal.

Il explore également l'importance d'organiser des événements Choisir avec soin.

Related Videos

KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer ( Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal )
27 Oct 2023
Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall...
Dr Neil Gross - MD Anderson Cancer Center, Houston, USA
Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall survival rates in patients with resectable CSCC ( Dr Neil Gross - MD Anderson Cancer Center, Houston, USA )
27 Oct 2023
OncoAlert Round Up for September 15-21, 2023
Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
25 Sep 2023
War in Ukraine: The Global Medical Knowledge Alliance's response to improving...
Prof Richard Sullivan, Asst. Prof Darya Kizub and Asst. Prof Nelya Melnitchouk
War in Ukraine: The Global Medical Knowledge Alliance's response to improving cancer care ( Prof Richard Sullivan, Asst. Prof Darya Kizub and Asst. Prof Nelya Melnitchouk )
22 Aug 2023
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast...
Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German )
2 May 2023
VT3989 is safe and well tolerated in patients with advanced malignant...
Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023
Cancer Care in Older Adults and Special Population
Dr Don Dizon - Rhode Island Hospital, Rhode Island, USA
Cancer Care in Older Adults and Special Population ( Dr Don Dizon - Rhode Island Hospital, Rhode Island, USA )
20 Apr 2023
Advancing breast cancer diagnosis in the developing world
Dr Hans Junkermann, Prof Dr.Erkin Arıbal and Dr Richard Rainsbury
Advancing breast cancer diagnosis in the developing world ( Dr Hans Junkermann, Prof Dr.Erkin Arıbal and Dr Richard Rainsbury )
21 Mar 2023
IORT at the Asian Hospital and Medical Center
Dr Aldine Basa - Asian Hospital and Medical Center, Manila, Philippines
IORT at the Asian Hospital and Medical Center ( Dr Aldine Basa - Asian Hospital and Medical Center, Manila, Philippines )
9 Mar 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation